Pulse nav.journalClub トレンド探索質問研究者

Download the App

Join discussions, follow papers, and never miss your next session.

© Synapse Social LLC, 2026プライバシーポリシー

synapseベータ

⌘+K

March 14, 2024Open Access

メディケイドにおける抗肥満薬の州カバレッジと償還

Read Full Paperexternally

Key Points

Key points are not available for this paper at this time.

Abstract

この研究は、メディケイドの抗肥満薬に関する州のカバレッジポリシーと、2011年から2022年までのメディケイド償還の傾向を調査します。

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Cite this study

Liu et al.（木曜日）は、この問題を研究しました。

synapsesocial.com/papers/68e73fdcb6db6435876b95cb — DOI: https://doi.org/10.1001/jama.2024.3073

Authors

B

Benjamin Y. Liu

Cornell University

B

Benjamin N. Rome

Boston University

Journals

JAMA

Actions

Institutions

Brigham and Women's Hospital

Beth Israel Deaconess Medical Center

References and Citations

Connected Papers

Building similarity graph...

Analyzing shared references across papers

Discussion

Loading...

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Spending, utilization, and price trends for anti-obesity medications in U.S. Medicaid programs: an empirical analysis from 1999 to 2023· 2025 · 2 citations
Navigating coverage: A qualitative study exploring the perceived impact of an insurance company policy to discontinue coverage of antiobesity medication· 2024 · 6 citations
Coverage for Opioid Use Disorder Medications in Medicaid Managed Care· 2025 · 2 citations
The Benefits and Costs of Treating Obesity Among Adults in the Medicaid Program· 2026
Survey-Reported Coverage in 2019-2022 and Implications for Unwinding Medicaid Continuous Eligibility· 2024 · 28 citations

メディケイドにおける抗肥満薬の州のカバレッジと償還 | Synapse